Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer
Table 7
Per capita workloss days and costs during the 12-month study period.
Employee subsample
Cases
Controls
-valuea
No.
%
No.
%
78
78
Workloss rateb
Medically related absenteeism
74
95%
76
97%
0.4142
Disability
27
35%
20
26%
0.2367
Workloss days
mean
(SD)
Mean
(SD)
-valuea
Medically related absenteeism
31.5
(28.1)
25.3
(18.2)
0.0573
Disability
37.4
(75.4)
20.4
(50.8)
0.1048
Workloss costs
mean
(SD)
mean
(SD)
-valuea
Total employer costs
$11,298
($11,830)
$9,043
($12,416)
0.2161
Medically related absenteeism
$6,329
($7,136)
$5,687
($6,200)
0.5012
Disability
$4,970
($10,994)
$3,356
($10,284)
0.3134
SD indicates standard deviation.
a-values are determined using McNemar tests for proportions and paired -tests for continuous measures.
bWorkloss rate defined as the number of people with ≥1 disability claim or ≥1 instance of medically-related absenteeism.